Frequency, duration, and cost of pulmonary exacerbations among patients with bronchiectasis

Exacerbations identified using a cost-based algorithm frequently lasted >3 weeks. Patients with cost-based exacerbations had higher healthcare costs, particularly respiratory costs, than those without.